课题基金 / 基金详情

项目摘要

项目成果

STEVAN R. HUBBARD的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY KCa3.1, also known as SK4 or IK1, is a member of a family of small- to intermediate-conductance potassium channels in humans (KCa2.1–2.3, KCa3.1). KCa3.1 plays a crucial role in T-cell activation by effluxing potassium to maintain a negative membrane potential that allows for additional calcium influx. KCa3.1 is a potential therapeutic target for inflammatory bowel diseases such as Crohn's disease and ulcerative colitis and for organ transplant rejection. KCa3.1 (and KCa2.1–2.3) is homotetrameric and activated through calcium binding to calmodulin (CaM), which is constitutively associated with a cytoplasmic region of the channels (CaM binding domain, CaMBD). A novel feature of KCa3.1 activation is the additional requirement of phosphorylation of a specific histidine residue (His358), just downstream of the CaMBD, by NDPK-B (nucleoside diphosphate kinase-B). Although histidine phosphorylation is well characterized in two-component signaling systems in prokaryotes, the functional consequences of histidine phosphorylation in eukaryotes are just beginning to be understood. Recently, we showed that histidine phosphorylation of KCa3.1 is necessary to relieve copper inhibition of the channel. In this application, cryo-EM studies are proposed to elucidate the molecular mechanisms by which KCa3.1 is regulated by calcium and histidine phosphorylation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structural Studies of the Potassium Channel KCa3.1
Regulation of the potassium channel IK1 by calcium and histidine phosphorylation
Structural Studies of the Pseudokinase Domain of Jak2
Structural Studies of the Pseudokinase Domain of Jak2.
国内基金
海外基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis